- Record: found
- Abstract: not found
- Article: not found
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Julio Rosenstock ,
Carol Wysham ,
Juan P Frías ,
Shizuka Kaneko ,
Clare J Lee ,
Laura Fernández Landó ,
Huzhang Mao ,
Xuewei Cui ,
Chrisanthi A Karanikas ,
Vivian T Thieu
June 2021
June 2021
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.